Analysts Set Genus plc (LON:GNS) Target Price at GBX 2,803.75
Shares of Genus plc (LON:GNS) have earned a consensus rating of “Buy” from the six analysts that are currently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is GBX 2,803.75 ($36.64).
Several research analysts have issued reports on GNS shares. Stifel Nicolaus started coverage on shares of Genus in a report on Wednesday, May 29th. They set a “hold” rating and a GBX 2,685 ($35.08) target price on the stock. Peel Hunt reiterated a “buy” rating and set a GBX 3,200 ($41.81) target price on shares of Genus in a report on Wednesday, September 11th. Liberum Capital restated a “buy” rating on shares of Genus in a report on Friday, September 6th. Finally, Peel Hunt restated a “buy” rating on shares of Genus in a report on Monday, September 16th.
Genus stock traded up GBX 56 ($0.73) during midday trading on Monday, hitting GBX 2,990 ($39.07). 286,269 shares of the company’s stock were exchanged, compared to its average volume of 78,154. The company has a debt-to-equity ratio of 21.92, a quick ratio of 1.19 and a current ratio of 2.01. Genus has a 12 month low of GBX 2,090 ($27.31) and a 12 month high of GBX 2,950 ($38.55). The firm has a 50-day moving average of GBX 2,660.80 and a two-hundred day moving average of GBX 2,525.72. The company has a market cap of $1.95 billion and a PE ratio of 251.26.
In other news, insider Lysanne Gray sold 1,298 shares of the firm’s stock in a transaction dated Monday, September 16th. The shares were sold at an average price of GBX 2,858 ($37.34), for a total value of £37,096.84 ($48,473.59). Also, insider Dan Hartley sold 7,267 shares of the stock in a transaction that occurred on Wednesday, September 18th. The shares were sold at an average price of GBX 2,894 ($37.82), for a total transaction of £210,306.98 ($274,803.32).
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.
Featured Article: What is Net Asset Value (NAV)?
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.